You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 48 No. 9, September 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  BOOKS
 This Article
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Neurobehavioral Aspects of Multiple Sclerosis

edited by S. M. Rao, 271 pp, with illus, $39.95, New York, NY, Oxford University Press Inc, 1990.

George C. Ebers, MD, Reviewer
London, Ontario

Arch Neurol. 1991;48(9):897.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

This small monograph, with contributions by 28 authors, focuses on cognitive and affective alterations in multiple sclerosis (MS). It is divided into four parts: clinicopathological features (84 pages), cognitive dysfunction (91 pages), affective disturbance in MS (35 pages), and management of neurobehavioral dysfunction (52 pages). It is correctly pointed out in the introduction that cognitive dysfunction in MS tends to be overlooked or discounted by physicians. On the other hand, this is often less because of lack of awareness and disinterest and more because of the desire to lighten the already burdensome knowledge of having a disabling neurological disorder. There are situations in which the identification of cognitive impairment in MS is not necessarily to the patient's advantage (eg, custody battles for children). However, the innate variability of human behavior requires a considerable latitude in determining what and how patients should be told about cognitive dysfunction. Furthermore, health professionals need . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.